DIP
NVO

DT Investment Partners’s Novo Nordisk NVO Stock Holding History

DT Investment Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-542
Closed -$30.1K – 557
2025
Q3 		$30.1K Hold
542
– – ﹤0.01% 288
2025
Q2 		$37.4K Hold
542
– – ﹤0.01% 261
2025
Q1 		$37.6K Hold
542
– – ﹤0.01% 255
2024
Q4 		$46.6K Hold
542
– – ﹤0.01% 239
2024
Q3 		$64.5K Hold
542
– – 0.01% 226
2024
Q2 		$77.4K Hold
542
– – 0.01% 206
2024
Q1 		$69.6K Hold
542
– – 0.01% 202
2023
Q4 		$59.1K Hold
542
– – 0.01% 210
2023
Q3 		$49.3K Buy
+542
New +$47.7K 0.01% 204

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DT Investment Partners's NVO Position: Q4 2025 in Review

DT Investment Partners sold out of Novo Nordisk (NVO) in Q4 2025, closing a stake of 542 shares — an estimated $30.1K sold.

DT Investment Partners first reported a position in NVO in Q3 2023 and held it in 9 quarters. The position peaked at $77.4K in Q2 2024. 1,413 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • DT Investment Partners reported no remaining Novo Nordisk position as of Q4 2025 after selling out during the quarter.
  • DT Investment Partners sold 542 Novo Nordisk shares in Q4 2025, an estimated $30.1K.
  • DT Investment Partners first reported a position in Novo Nordisk in Q3 2023 and held it in 9 quarters.
  • DT Investment Partners's Novo Nordisk position peaked at $77.4K in Q2 2024.
  • 1,413 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on DT Investment Partners's 13F filing for Q4 2025, filed 10 Feb 2026.